vomiting; headache; this is a spontaneous report received from a contactable reporter (consumer) from the ra. regulatory number: gb-mhra-webcovid-202202271200174650-vwv0a. other case identifier(s): gb-mhra-adr 26657139. a 12 year-old female patient received bnt162b2 (comirnaty), administration date 25feb2022 (lot number: fn1665) as dose number unknown, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. patient did not have symptoms associated with covid-19. patient was not enrolled in clinical trial. the following information was reported: headache (medically significant) with onset feb2022, outcome "recovering", described as "headache"; vomiting (medically significant) with onset 26feb2022, outcome "recovering", described as "vomiting". vomiting started approximately 12 hours later. lasting 8 hours (as reported). the patient underwent the following laboratory tests and procedures: sars-cov-2 test: no - negative covid-19 test. patient did not test positive for covid-19 since having the vaccine. the report was not related to possible inflammation of the heart (myocarditis or pericarditis). no follow-up attempts are possible. no further information is expected

test name: covid-19 virus test; result unstructured data: test result:no - negative covid-19 test

na

na